Kineta Inc. (NASDAQ: KA)
$0.73
-0.0020 ( -0.27% ) 76.5K
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
Market Data
Open
$0.73
Previous close
$0.73
Volume
76.5K
Market cap
$8.82M
Day range
$0.71 - $0.79
52 week range
$0.33 - $5.39
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Jul 08, 2024 |
| 8-k | 8K-related | 11 | Jun 25, 2024 |
| 8-k | 8K-related | 11 | May 30, 2024 |
| 10-q | Quarterly Reports | 75 | May 15, 2024 |
| 8-k | 8K-related | 13 | May 15, 2024 |
| 4 | Insider transactions | 1 | May 02, 2024 |
| def | Proxies and info statements | 7 | Apr 26, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |
| 8-k | 8K-related | 12 | Apr 24, 2024 |
| 8-k | 8K-related | 11 | Apr 18, 2024 |